CClinicalTrials.gg
Sign In
WithdrawnNCT02210676Updated Dec 22, 2016

Residual Extensor Lag Approximately 1 Month After Splint or Cast Immobilization of a Mallet Finger

An interventional study of PROMIS Upper Extremity and Likert Pain Scale in Patients Present With Mallet Finger, sponsored by Massachusetts General Hospital. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-12-22.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Health services research

Why this study was withdrawn
Due to the investigator leaving the institution, the study was terminated
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Aim:

The purpose of the study is to learn more about how a person recovers after treatment for mallet finger injury. The investigators want to identify the best outcome after mallet finger injury and how to improve treatment strategies.

Primary null hypothesis:

There are no statistically significant factors associated with extensor lag between 4 weeks and 4 months after immobilization is discontinued for a mallet finger among demographic, injury, and treatment factors.

Secondary null hypothesis:

There are no statistically significant factors associated with PROMIS upper extremity function between 4 weeks and 4 months after completion of immobilization for a mallet finger among demographic, psychological, injury, and treatment factors.

02

Conditions studied

  • Patients Present With Mallet Finger
03

In context

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.

Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years of age and older
  • English fluency and literacy
  • Mallet finger fracture or non-fracture
  • Mallet finger subluxation or non-subluxation

Exclusion criteria

Exclusion Criteria:

  • Pregnant Women
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Patients with Mallet Finger

    All enrolled patients

    Other: PROMIS Upper Extremity · Other: Likert Pain Scale · Other: Mallet Finger Extensor Lag Measurement

Interventions

  • OtherPROMIS Upper Extremity
  • OtherLikert Pain Scale
  • OtherMallet Finger Extensor Lag Measurement
06

What researchers measure

Primary outcomes

  1. Mallet Finger Extensor Lag

    Time frame: Baseline

  2. Mallet Finger Extensor Lag

    Time frame: 4 weeks to 4 months after diagnosis

Secondary outcomes

  1. Patient Reported Outcomes Measure Information System (PROMIS) Upper Extremity

    A computerized assessment of upper extremity function

    Time frame: 4 weeks to 4 months after diagnosis

  2. Likert Pain Scale

    Time frame: 4 weeks to 4 months after diagnosis

  3. Demographics Questionnaire

    Time frame: 4 weeks to 4 months after diagnosis

07

Study locations

1 site
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 22, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02210676
Lead sponsor
Massachusetts General Hospital
Responsible party
David C. Ring, MD (Principal Investigator, Massachusetts General Hospital) — Principal investigator
First posted
Aug 7, 2014
Start date
Jun 2014
Primary completion
Jan 2016
Last update
Dec 22, 2016

Study contacts

David Ring, MD PhD
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Massachusetts General Hospital

Start the discussion